Share Prices & Company Research

Market News

15 Jan 2019 | 14:25

Collagen Solutions partners with Olaregen Therapeutix to make wound treatment

Collagen Solutions said it had formed an agreement with Olaregen Therapeutix to produce a treatment for hard-to-heal wounds such as diabetic foot ulcers.

The company said it would support the launch of Olaregen's launch of its so-called Excellagen product in the first half of 2019.

'This new agreement is consistent with our strategy to move up the value chain by collaborating with industry partners to develop and launch innovative products designed to improve patients' lives,' chief executive Jamal Rushdy said.

At 2:25pm: (LON:COS) Collagen Solutions Plc share price was +0.2p at 3.85p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.